U.S. Markets closed
  • S&P 500

    3,785.38
    -33.45 (-0.88%)
     
  • Dow 30

    30,775.43
    -253.88 (-0.82%)
     
  • Nasdaq

    11,028.74
    -149.16 (-1.33%)
     
  • Russell 2000

    1,707.99
    -11.38 (-0.66%)
     
  • Crude Oil

    105.87
    -3.91 (-3.56%)
     
  • Gold

    1,807.80
    -9.70 (-0.53%)
     
  • Silver

    20.25
    -0.49 (-2.38%)
     
  • EUR/USD

    1.0489
    +0.0045 (+0.4300%)
     
  • 10-Yr Bond

    2.9720
    -0.1210 (-3.91%)
     
  • Vix

    28.71
    +0.55 (+1.95%)
     
  • GBP/USD

    1.2178
    +0.0056 (+0.4579%)
     
  • USD/JPY

    135.6700
    -0.8750 (-0.6408%)
     
  • BTC-USD

    18,764.06
    -1,434.56 (-7.10%)
     
  • CMC Crypto 200

    404.82
    -26.65 (-6.18%)
     
  • FTSE 100

    7,169.28
    -143.04 (-1.96%)
     
  • Nikkei 225

    26,393.04
    -411.56 (-1.54%)
     

Weekly CFO Buys Highlight

  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

- By Myra Ramdenbourg

According to GuruFocus Insider Data, the recent CFO buys were: Tronox Ltd (TROX), Synthorx Inc. (THOR) and RTI Surgical Inc. (RTIX).

Tronox Ltd: SVP and CFO Timothy C. Carlson bought 21,000 shares

SVP and CFO Timothy C. Carlson bought 21,000 shares for $7.15 per share on Dec. 11. Since then, the stock price has increased by 4.76%. Tronox Ltd. has a market cap of $920.774 million and its shares were traded around $7.49. The company has a price-sales ratio of 0.50. The trailing 12-month dividend yield of Tronox Ltd. stocks is 2.40%, while the forward dividend yield is 2.40%.


Tronox Ltd. announced its third-quarter results with revenue of $456 million and gross profit of $121 million, while the net income was $6 million. The 2017 total revenue was $1.70 billion, a 30% increase from 2016. The 2017 gross profit was $388 million, a 190% increase from the year prior. The 2017 net loss was $285 million.

President and CEO Jeffry N. Quinn bought 25,000 shares for $7.21 per share on Dec. 10. Since then, the stock price has increased by 3.88%. Senior Vice President General Counsel and Secretary Jeffrey N. Neuman bought 6,500 shares for $7.81 per share on Dec. 7. Since then, the stock price has decreased by 4.1%. Senior Vice President Strategic Planning and B. Niekerk Willem Hendrik Van bought 3,800 shares for $7.44 per share on Dec. 7. Since then, the stock price has increased by 0.67%.

Synthorx Inc.: Acting CFO Tighe Reardon bought 545,455 shares

Acting CFO Tighe Reardon bought 545,455 shares for $11 per share on Dec. 11. Since then, the stock price has increased by 35.45%. Synthorx Inc. has a market cap of $450.432 million and its shares were traded around $14.90.

Director, 10% Owner Peter A. Thompson bought 1,363,636 shares for $11 per share on Dec. 11. Since then, the stock price has increased by 35.45%. Director, 10% Owner Jay Lichter bought 545,455 shares for $11 per share on Dec. 11. Since then, the stock price has increased by 35.45%. Director, 10% Owner Advisors LLC Orbimed bought 1,363,636 shares for $11 per share on Dec. 11. Since then, the stock price has increased by 35.45%.

RTI Surgical Inc.: CFO/CAO Jonathon M. Singer bought 50,000 shares

CFO/CAO Jonathon M Singer bought 50,000 shares for $4.28 per share on Dec. 12. Since then, the stock price has decreased by 3.04%. RTI Surgical Inc. has a market cap of $263.366 million and its shares were traded around $4.15. The company has a price-sales ratio of 0.95.

RTI Surgical announced its third-quarter results with revenue of $69.06 million and gross profit of $37.66 million, while the net income was $3.10 million. The 2017 total revenue was $279.56 million, a 3% increase from 2016. The 2017 gross profit was $142.52 million, a 8% increase from the year prior. The 2017 net income was $6.27 million.

CEO Camille Farhat bought 11,516 shares for $3.85 per share on Dec. 10. Since then, the stock price has increased by 7.79%.

Disclosure: none.

This article first appeared on GuruFocus.